What is the main business of Esthetic Solutions?

The main business activity of Esthetic Solutions focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 30, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Maurycego Beniowskiego 13, 81-226 Gdynia.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2020 to December 31, 2020.

What revenue was generated?

In 2020, the company generated total revenue of $17,568, representing an increase of 10840.1% compared to 2019.

Is the company profitable?

No, the company recorded a net loss of $1,894 in 2020. For comparison, in 2019 the loss was $2,143, meaning the company reduced its loss by 10.3%.

What is the main operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $17,381 in 2020, representing 90% of all operating expenses.

Esthetic Solutionssp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-06-30

Share capital

5,000.00 PLN

Registered address

ul. Maurycego Beniowskiego 13, 81-226 Gdynia, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2021 – the filing deadline has passed.

2021not filed
202006/07/2021
201915/07/2020
201821/03/2019

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2020.

Results vs industry

Revenue

This companyUSD 17.57kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -1.89kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 19.38kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 48.01kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Alexander Blyuman – President of the Management Board

Eleonora Blyuman – Attorney-in-fact (sole)

Manner of representation

Each member of the management board is independently authorised to submit declarations on behalf of the company and to represent the company.

Ownership

Owner	Shares	Share value	Stake
Alexander Blyumanage 66	45	$1,215.56	90%
Eleonora Blyuman	5	$135.06	10%

Alexander Blyuman and Eleonora Blyuman hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2015-09-14 to 2025-12-08.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

1 closed proceeding recorded in KRZ history.

Registration date	Proceeding type	Status
May 29, 2024	Discontinued enforcement proceedings	Closed

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Livistosp. z o.o.	$17,956,135.04	livisto.pl
ODA Medicalsp. z o.o.	$9,414,794.43	odamedical.pl
Diather Petrusewiczsp. k.	$6,475,149.95	diather.pl
Vet-Animalsp. z o.o.	$3,655,323.77	vet-animal.pl
Mikamedsp. z o.o.	$1,938,472.05	mikamed.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
GROW Pharmasp. z o.o.	$15,020.86	growpharma.pl
Beyond Medical Aesthetics Polskasp. z o.o.	$13,696.94	bmapolska.pl
Beokasp. z o.o.	–	beoka.pl

Change history

Date	Event
2025-06-02	Business resumed
2022-08-16	Business suspended
2015-06-30	Entered in the register

FAQ

Last updated: 2026-04-13